Clinical Research Organisation - Aixial Group

Larixcro. Aixial Group is a clinical research organisation with the expertise, and flexibility needed to deliver efficient clinical trials..

Read Larixcro.com news digest here: view the latest Larixcro articles and content updates right away or get to their most visited pages. Larixcro.com is not yet rated by Alexa. We haven’t detected security issues or inappropriate content on Larixcro.com and thus you can safely use it. Larixcro.com is hosted with GANDI FRANCE L/B SERVICES (France) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:
  • 489

    Visitors daily
  • 489

    Pageviews daily
  • N/A

    Google PR
  • N/A

    Alexa rank

Larixcro.com news digest

  • 11 months

    Cmed and Larix fully integrate into Aixial Group, the CRO solution of ALTEN GROU...

    Cmed and Larix fully integrate into Aixial Group
    Press release – May 30th 2023
    Following its acquisition of Larix in 2019 and Cmed Group in 2021, Aixial Group has become a leading mid-size, global CRO, with strong US and European presence and more than 1,000 employees....

  • 11 months

    Rare Diseases: Phase I First-in-Human Study on Wilson’s Disease

    Rare Diseases: Phase I First-in-Human Study on Wilson’s Disease
    Case study
    This case study looks at the challenges that arose in a Phase I First In Human trial for the progressive Wilson’s Disease, and how the expert team at Cmed overcame these challenges for the sponsor....

  • 11 months

    Cell & Gene Therapy: Safety and Clinical Activity in Patients with Relapsed or R...

    Cell & Gene Therapy: Safety and Clinical Activity in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma
    Case study
    Cell and gene therapy trials can present a multitude of challenges. Aixial Group experts employ real time insights and hands-on management to expedite dosing escalation reviews, ensure proactive management of IP, and provide enhanced site support....

  • 11 months

    Rare Diseases: Phase II Pediatric Study with Selected Metabolic Disorders

    Rare Diseases: Phase II Pediatric Study with Selected Metabolic Disorders
    Case study
    Aixial Group is currently working on a Phase II trial with a US Pharmaceutical company involving pediatric patients with selected inherited metabolic disorders undergoing stem cell transplantation....

Domain history

Web host: GANDI FRANCE L/B SERVICES
Registrar: Gandi SAS
Registrant: REDACTED FOR PRIVACY (AIXIAL)
Updated: February 28, 2024
Expires: December 16, 2024
Created: December 16, 2014

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A